{
    "SPADE_UN_22445": {
        "Sequence Information": {
            "Peptide Name": "Chionodracine [F1W;S11,21K;H4,15,17K]",
            "Sequence": "WFGKLYRGITKVVKKVKGLLKG",
            "Sequence Length": 22,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "K4Q515",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/K4Q515",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens",
                    "Pubmed ID": "",
                    "Reference": "RSC Adv. 2018;8:41331-41346",
                    "Author": "Olivieri C, Bugli F, Menchinelli G, Veglia G, Buonocore F, Scapigliati G, Stocchi V, Ceccacci F, Papi M, Sanguinetti M, Porcelli F",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"
                }
            ],
            "Mass": 2519.12,
            "PI": 10.75,
            "Net Charge": 7,
            "Hydrophobicity": -0.05,
            "Frequent Amino Acids": "KGL",
            "Absent Amino Acids": "ACDEHMNOPQSU",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 14,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_22445",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_22445",
                    "Similarity": 1.0,
                    "Sequence": "WFGKLYRGITKVVKKVKGLLKG"
                },
                {
                    "SPADE_ID": "SPADE_UN_15814",
                    "Similarity": 0.9545454545454546,
                    "Sequence": "WFGKLYRGKTKVVKKVKGLLKG"
                },
                {
                    "SPADE_ID": "SPADE_N_14380",
                    "Similarity": 0.9090909090909091,
                    "Sequence": "WFGKLYRGITSVVKKVKGLLSG"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:10% Hemolysis=13 µM,Human erythrocytes:24% Hemolysis=50 µM,Human fibroblasts FB789:40% Killing=6.3 µM,Human fibroblasts FB789:100% Killing=25 µM",
            "Target Organism": "Klebsiella pneumoniae(MIC=0.6µM),Klebsiella pneumoniae(MBC=2.5µM),Escherichia coli(MIC=1.2µM),Escherichia coli(MBC=2.5µM),Acinetobacter baumannii(MIC=0.6µM),Acinetobacter baumannii(MBC=2.5µM),Pseudomonas aeruginosa(MIC=1.3µM),Pseudomonas aeruginosa(MBC=5.0µM),Staphylococcus aureus(MIC=9.9µM),Staphylococcus aureus(MBC=19.9µM),Staphylococcus epidermidis(MIC=1.2µM),Staphylococcus epidermidis(MBC=3.7µM),Enterococcus faecalis(MIC=1.2µM),Enterococcus faecalis(MBC=2.5µM)"
        }
    }
}